Qixu Investment Management

Qixu pursues a balanced strategy that combines growth equity and buyout transactions in China's middle market. The firm targets direct control and significant minority positions, typically investing between $50 million and $300 million in enterprise value per deal. This dual mandate allows it to underwrite both high-growth scaling companies and mature businesses requiring operational restructuring.

Qixu focuses on three core sectors: Technology, Healthcare, and Consumer. These verticals align with China's long-term structural trends of domestic consumption upgrade and indigenous innovation. The firm's generalist posture within these broad areas enables it to pursue cross-sector opportunities as they emerge.

Qixu relies on its proprietary network in China's first- and second-tier cities to source opportunities from family-held businesses and corporate carve-outs. The firm participates in both limited auctions and direct bilateral negotiations, with an emphasis on proprietary origination where local relationships provide an informational advantage over larger competitors.

Qixu raises capital from Chinese institutional investors, including insurance companies, government guidance funds, and domestic family offices. The firm's limited partner base reflects the institutionalization of local capital pools that have grown alongside China's private equity industry over the past decade.

No. Qixu is structured as an independent private equity firm, not a single-family office. It manages third-party capital from institutional investors on a fund and co-investment basis, operating as a conventional asset manager rather than the dedicated wealth-management arm of a specific family.